337 related articles for article (PubMed ID: 23273833)
1. Epigenetic regulation of opioid-induced hyperalgesia, dependence, and tolerance in mice.
Liang DY; Li X; Clark JD
J Pain; 2013 Jan; 14(1):36-47. PubMed ID: 23273833
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of spinal cord gene expression controls opioid-induced hyperalgesia.
Liang DY; Sun Y; Shi XY; Sahbaie P; Clark JD
Mol Pain; 2014 Sep; 10():59. PubMed ID: 25217253
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic regulation of spinal cord gene expression contributes to enhanced postoperative pain and analgesic tolerance subsequent to continuous opioid exposure.
Sahbaie P; Liang DY; Shi XY; Sun Y; Clark JD
Mol Pain; 2016; 12():. PubMed ID: 27094549
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic regulation of spinal CXCR2 signaling in incisional hypersensitivity in mice.
Sun Y; Sahbaie P; Liang DY; Li WW; Li XQ; Shi XY; Clark JD
Anesthesiology; 2013 Nov; 119(5):1198-208. PubMed ID: 23756451
[TBL] [Abstract][Full Text] [Related]
5. Tolerance, opioid-induced allodynia and withdrawal associated allodynia in infant and young rats.
Zissen MH; Zhang G; McKelvy A; Propst JT; Kendig JJ; Sweitzer SM
Neuroscience; 2007 Jan; 144(1):247-62. PubMed ID: 17055659
[TBL] [Abstract][Full Text] [Related]
6. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
Dunbar SA; Karamian I; Zhang J
Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
[TBL] [Abstract][Full Text] [Related]
7. Lipoxin A4 analog attenuates morphine antinociceptive tolerance, withdrawal-induced hyperalgesia, and glial reaction and cytokine expression in the spinal cord of rat.
Jin H; Li YH; Xu JS; Guo GQ; Chen DL; Bo Y
Neuroscience; 2012 Apr; 208():1-10. PubMed ID: 22366510
[TBL] [Abstract][Full Text] [Related]
8. Modulation of histone deacetylase attenuates naloxone-precipitated opioid withdrawal syndrome.
Rehni AK; Singh N; Rachamalla M; Tikoo K
Naunyn Schmiedebergs Arch Pharmacol; 2012 Jun; 385(6):605-19. PubMed ID: 22362134
[TBL] [Abstract][Full Text] [Related]
9. The Netrin-1 receptor DCC is a regulator of maladaptive responses to chronic morphine administration.
Liang DY; Zheng M; Sun Y; Sahbaie P; Low SA; Peltz G; Scherrer G; Flores C; Clark JD
BMC Genomics; 2014 May; 15(1):345. PubMed ID: 24884839
[TBL] [Abstract][Full Text] [Related]
10. HDAC inhibitor TSA ameliorates mechanical hypersensitivity and potentiates analgesic effect of morphine in a rat model of bone cancer pain by restoring μ-opioid receptor in spinal cord.
Hou X; Weng Y; Ouyang B; Ding Z; Song Z; Zou W; Huang C; Guo Q
Brain Res; 2017 Aug; 1669():97-105. PubMed ID: 28559159
[TBL] [Abstract][Full Text] [Related]
11. Effect of histone acetylation on maintenance and reinstatement of morphine-induced conditioned place preference and ΔFosB expression in the nucleus accumbens and prefrontal cortex of male rats.
Saberian H; Asgari Taei A; Torkaman-Boutorabi A; Riahi E; Aminyavari S; Naghizadeh A; Farahmandfar M
Behav Brain Res; 2021 Sep; 414():113477. PubMed ID: 34302880
[TBL] [Abstract][Full Text] [Related]
12. Microinjection of histone deacetylase inhibitor into the ventrolateral orbital cortex potentiates morphine induced behavioral sensitization.
Wei L; Zhu YM; Zhang YX; Liang F; Barry DM; Gao HY; Li T; Huo FQ; Yan CX
Brain Res; 2016 Sep; 1646():418-425. PubMed ID: 27312092
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants of the P-glycoprotein gene Abcb1b modulate opioid-induced hyperalgesia, tolerance and dependence.
Liang DY; Liao G; Lighthall GK; Peltz G; Clark DJ
Pharmacogenet Genomics; 2006 Nov; 16(11):825-35. PubMed ID: 17047491
[TBL] [Abstract][Full Text] [Related]
14. Preprotachykinin-A gene disruption attenuates nociceptive sensitivity after opioid administration and incision by peripheral and spinal mechanisms in mice.
Sahbaie P; Shi X; Li X; Liang D; Guo TZ; Qiao Y; Yeomans DC; Kingery WS; David Clark J
J Pain; 2012 Oct; 13(10):997-1007. PubMed ID: 23031399
[TBL] [Abstract][Full Text] [Related]
15. Chronic Morphine-Induced Changes in Signaling at the A
Doyle TM; Largent-Milnes TM; Chen Z; Staikopoulos V; Esposito E; Dalgarno R; Fan C; Tosh DK; Cuzzocrea S; Jacobson KA; Trang T; Hutchinson MR; Bennett GJ; Vanderah TW; Salvemini D
J Pharmacol Exp Ther; 2020 Aug; 374(2):331-341. PubMed ID: 32434943
[TBL] [Abstract][Full Text] [Related]
16. The multiple PDZ domain protein Mpdz/MUPP1 regulates opioid tolerance and opioid-induced hyperalgesia.
Donaldson R; Sun Y; Liang DY; Zheng M; Sahbaie P; Dill DL; Peltz G; Buck KJ; Clark JD
BMC Genomics; 2016 Apr; 17():313. PubMed ID: 27129385
[TBL] [Abstract][Full Text] [Related]
17. HDAC and HAT inhibitors differently affect analgesia mediated by group II metabotropic glutamate receptors.
Zammataro M; Sortino MA; Parenti C; Gereau RW; Chiechio S
Mol Pain; 2014 Nov; 10():68. PubMed ID: 25406541
[TBL] [Abstract][Full Text] [Related]
18. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance.
Vanderah TW; Gardell LR; Burgess SE; Ibrahim M; Dogrul A; Zhong CM; Zhang ET; Malan TP; Ossipov MH; Lai J; Porreca F
J Neurosci; 2000 Sep; 20(18):7074-9. PubMed ID: 10995854
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine fails to cause hyperalgesia after cessation of chronic administration.
Davies MF; Haimor F; Lighthall G; Clark JD
Anesth Analg; 2003 Jan; 96(1):195-200, table of contents. PubMed ID: 12505952
[TBL] [Abstract][Full Text] [Related]
20. Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.
Elhabazi K; Trigo JM; Mollereau C; Moulédous L; Zajac JM; Bihel F; Schmitt M; Bourguignon JJ; Meziane H; Petit-demoulière B; Bockel F; Maldonado R; Simonin F
Br J Pharmacol; 2012 Jan; 165(2):424-35. PubMed ID: 21718302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
